This episode features recent updates presented at the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Germany. Lisa Rauh-Benoit, MD, MPH, and Michelle Boisen, MD discuss data presented for trials including DUO-O, Rina-S/RAINFOL-1 , TV 205 and more, highlighting the key takeaways and implications for practice. 

View the accompanying PDF resource developed by the SGO Education Committee here (https://connected.sgo.org/content/highlights-esmo-2025).